NovaBay Pharmaceuticals NBY Stock
NovaBay Pharmaceuticals Price Chart
NovaBay Pharmaceuticals NBY Financial and Trading Overview
| NovaBay Pharmaceuticals stock price | 1.15 USD |
| Previous Close | 0.7 USD |
| Open | 0.68 USD |
| Bid | 0.49 USD x 1000 |
| Ask | 0 USD x 1400 |
| Day's Range | 0.66 - 0.7 USD |
| 52 Week Range | 0.48 - 12.6 USD |
| Volume | 77.6K USD |
| Avg. Volume | 482.13K USD |
| Market Cap | 2.84M USD |
| Beta (5Y Monthly) | 2.768309 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 2.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 USD |
NBY Valuation Measures
| Enterprise Value | 3.1M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.821429 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.1993288 |
| Price/Book (mrq) | 0.2321183 |
| Enterprise Value/Revenue | 0.218 |
| Enterprise Value/EBITDA | -0.469 |
Trading Information
NovaBay Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 2.768309 |
| 52-Week Change | -90.28% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.6 USD |
| 52 Week Low | 0.48 USD |
| 50-Day Moving Average | 1.04 USD |
| 200-Day Moving Average | 2.42 USD |
NBY Share Statistics
| Avg. Volume (3 month) | 482.13K USD |
| Avg. Daily Volume (10-Days) | 220.55K USD |
| Shares Outstanding | 4.21M |
| Float | 2.55M |
| Short Ratio | 0.22 |
| % Held by Insiders | 14.60% |
| % Held by Institutions | 8.92% |
| Shares Short | 228.13K |
| Short % of Float | 5.41% |
| Short % of Shares Outstanding | 5.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -85.83% |
| Operating Margin (ttm) | -49.33% |
| Gross Margin | 55.43% |
| EBITDA Margin | -46.43% |
Management Effectiveness
| Return on Assets (ttm) | -22.18% |
| Return on Equity (ttm) | -91.87% |
Income Statement
| Revenue (ttm) | 14.26M USD |
| Revenue Per Share (ttm) | 8.1 USD |
| Quarterly Revenue Growth (yoy) | -4.59% |
| Gross Profit (ttm) | N/A |
| EBITDA | -6619000 USD |
| Net Income Avi to Common (ttm) | -17893000 USD |
| Diluted EPS (ttm) | -10.65 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.75M USD |
| Total Cash Per Share (mrq) | 1.37 USD |
| Total Debt (mrq) | 1.98M USD |
| Total Debt/Equity (mrq) | 22.25 USD |
| Current Ratio (mrq) | 2.237 |
| Book Value Per Share (mrq) | 2.908 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6208000 USD |
| Levered Free Cash Flow (ttm) | -3645000 USD |
Profile of NovaBay Pharmaceuticals
| Country | United States |
| State | CA |
| City | EmeryVille |
| Address | 2000 Powell Street |
| ZIP | 94608 |
| Phone | 510 899 8800 |
| Website | https://novabay.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Q&A For NovaBay Pharmaceuticals Stock
What is a current NBY stock price?
NovaBay Pharmaceuticals NBY stock price today per share is 1.15 USD.
How to purchase NovaBay Pharmaceuticals stock?
You can buy NBY shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NovaBay Pharmaceuticals?
The stock symbol or ticker of NovaBay Pharmaceuticals is NBY.
Which industry does the NovaBay Pharmaceuticals company belong to?
The NovaBay Pharmaceuticals industry is Biotechnology.
How many shares does NovaBay Pharmaceuticals have in circulation?
The max supply of NovaBay Pharmaceuticals shares is 6.01M.
What is NovaBay Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
NovaBay Pharmaceuticals PE Ratio is 0.50000000 now.
What was NovaBay Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
NovaBay Pharmaceuticals EPS is 2.3 USD over the trailing 12 months.
Which sector does the NovaBay Pharmaceuticals company belong to?
The NovaBay Pharmaceuticals sector is Healthcare.
NovaBay Pharmaceuticals NBY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE American Composite Index XAX | 6928.97 USD — |
-2.19
|
— — | 6910.38 USD — | 7115.63 USD — | — - | — — |
- {{ link.label }} {{link}}